Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Morrissey Donald J Jr
 2. Date of Event Requiring Statement (Month/Day/Year)
06/27/2006		 3. Issuer Name and Ticker or Trading Symbol
REPLIDYNE INC [RDYN]
(Last)
(First)
(Middle)
1450 INFINITE DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Sr. VP, Corporate Development
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

LOUISVILLE, CO 80027		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 100,258
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) 06/27/2006(1) 12/12/2012 Common Stock 11,895 $ 0.49 D  
Stock Option (right to buy) 06/27/2006(1) 06/09/2014 Common Stock 20,391 $ 0.61 D  
Stock Option (right to buy) 06/27/2006(1) 05/26/2015 Common Stock 12,234 $ 0.61 D  
Stock Option (right to buy) 06/27/2006(2) 01/19/2016 Common Stock 81,566 $ 3.19 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Morrissey Donald J Jr
1450 INFINITE DRIVE
LOUISVILLE, CO 80027		       Sr. VP, Corporate Development  

Signatures

/s/ Donald J. Morrissey 06/27/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Shares currently vest in equal monthly installments.
(2) 20,391 of the shares vest upon the earlier to occur of (A) the signing by the Company of a collaboration and commercialization agreement with Forest Laboratories Holdings Limited and (B) the fourth anniversary of the vesting commecement date; 12.5% of the remaining shares vest on the one year anniversary of the vesting commencement date; 37.5% of the remaining shares vest in equal monthly installments over 36 months beginning one month following the one year anniversary of the vesting commencement date; and 50% of the remaining shares vest upon the earlier to occur of (A) the fourth anniversary of the vesting commencement date; and (B) following the Company's consummation of its initial public offering, such day on which the closing price, as reported on the Nasdaq National Market quotation system, of the Company's Common Stock equals or exceeds a milestone price as set forth in the option grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.